Composecure (NYSE:GPGI – Get Free Report) was downgraded by Wall Street Zen from a “sell” rating to a “strong sell” rating in a report released on Sunday.
GPGI has been the subject of several other research reports. JPMorgan Chase & Co. cut their target price on Composecure from $22.00 to $15.00 and set a “neutral” rating for the company in a research note on Friday, May 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Composecure in a research report on Thursday, June 11th. Finally, Zacks Research downgraded shares of Composecure from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 14th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Composecure presently has a consensus rating of “Hold” and a consensus target price of $15.00.
Get Our Latest Stock Report on GPGI
Composecure Trading Down 0.6%
Composecure (NYSE:GPGI – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. The company had revenue of $421.20 million during the quarter. During the same period in the prior year, the firm earned $0.25 earnings per share. Equities analysts forecast that Composecure will post 0.9 earnings per share for the current year.
Insider Buying and Selling at Composecure
In other Composecure news, insider Kurt Schoen purchased 4,000 shares of the company’s stock in a transaction dated Wednesday, May 13th. The stock was purchased at an average price of $12.58 per share, for a total transaction of $50,320.00. Following the transaction, the insider owned 586,317 shares in the company, valued at $7,375,867.86. The trade was a 0.69% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Thomas R. Knott acquired 85,250 shares of the business’s stock in a transaction dated Thursday, June 11th. The shares were acquired at an average cost of $11.67 per share, with a total value of $994,867.50. Following the acquisition, the insider directly owned 129,250 shares of the company’s stock, valued at $1,508,347.50. This represents a 193.75% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 105,237 shares of company stock valued at $1,245,734 over the last 90 days. Insiders own 18.40% of the company’s stock.
Key Stories Impacting Composecure
Here are the key news stories impacting Composecure this week:
- Negative Sentiment: Multiple law firms, including Kaplan Fox, Glancy Prongay, Schall, Robbins, Wolf Haldenstein, Rosen, Pomerantz, Bernstein Liebhard, Kessler Topaz, DJS Law Group, and Robbins Geller, announced or reminded investors about a class action lawsuit against GPGI tied to alleged securities fraud and a lead-plaintiff deadline in mid-September 2026. Article Title
- Neutral Sentiment: GPGI announced that it will host its second-quarter 2026 earnings call on August 6, giving investors a near-term update on results and management commentary. Article Title
About Composecure
CompoSecure, Inc manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which comprise the Arculus Key card Cold Storage hardware device and companion Arculus Wallet mobile App to keep the Private Key in the Arculus Key card highly secure and store cryptocurrency and digital assets.
Further Reading
- Five stocks we like better than Composecure
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for Composecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Composecure and related companies with MarketBeat.com's FREE daily email newsletter.
